Mechanisms of change with early intervention in Tuberous Sclerosis Complex

结节性硬化症早期干预的变化机制

基本信息

项目摘要

PROJECT SUMMARY/ABSTRACT Background: Children with Tuberous Sclerosis Complex (TSC) are at high risk for neurodevelopmental disorders, with rates of autism spectrum disorder (ASD) approaching 60%. Prospective studies have found that infants with TSC demonstrate delays in social communication skills in the first year of life. However, to date no studies have investigated whether early behavioral intervention can improve social communication skills in infants with TSC. Objectives: The overarching goal of the study is to determine if social communication function can be improved in infants with TSC with a targeted, short-term behavioral intervention called JASPER (Joint Attention, Symbolic Play, Engagement, Regulation), and to enrich traditional outcome measures by combining behavioral measures with electrophysiological (EEG) biomarkers of social communication. These biomarkers can capture subtle changes in brain development that may reflect responses to treatment prior to an overt behavioral change, particularly relevant for children with significantly delayed development, and they can inform the neural mechanisms underlying the behavioral changes found with intervention. Hypothesis: It is expected that, compared to a wait list control group, infants receiving the JASPER intervention will demonstrate greater gains in social communication skills, with changes captured both behaviorally and electrophysiologically. Methodology: A total of 60 infants with TSC ages 12-36 months will be recruited across two sites with an established collaboration in TSC research, UCLA and Boston Children's Hospital, with each infant randomized to treatment or wait list control group. The wait list control design allows all infants to receive intervention while still maintaining a non-treatment comparison group. Treatment will consist of 12 weeks of weekly intervention sessions. Assessments (clinical, behavioral and EEG) will be performed before treatment, after treatment, 3 months after completion, and then 12 months after completion. Controls will undergo assessments at the same time points, and then will start intervention at month 6. Assessments will include behavioral measures of social communication skills, cognition, language and adaptive function, and EEG measure of resting state brain activity, visual and face processing. Impact: Early intervention improves cognitive and behavioral outcomes in ASD, yet no studies have investigated the effects of targeted, early behavioral intervention in infants with TSC. Evidence of efficacy of early intervention will justify its value for all infants with TSC, improving developmental outcomes and attenuating symptoms that lead to the diagnosis of neurodevelopmental disabilities in TSC. Moreover, this study holds relevance for intervention research across neurodevelopmental disorders through its integration of EEG biomarkers with behavioral measures, as such methodology may more readily capture the effects of treatment in pre-verbal and developmentally delayed infants.
项目摘要/摘要 背景:结节性硬化症复合物(TSC)的儿童有神经发育的高风险 疾病,自闭症谱系障碍(ASD)的率接近60%。前瞻性研究发现 患有TSC的婴儿表明,在生命的第一年,社会沟通技巧的延迟。但是,迄今为止否 研究已经调查了早期行为干预是否可以提高社会沟通能力 患有TSC的婴儿。目标:研究的总体目标是确定社会交流是否 具有针对性的短期行为干预措施的TSC婴儿可以改善功能 jasper(共同关注,象征性游戏,参与,监管),并丰富传统结果 通过将行为度量与社会生物学(EEG)生物标志物结合起来的措施 沟通。这些生物标志物可以捕获大脑发育的细微变化,这可能反映 明显的行为改变之前对治疗的反应,尤其是与患有明显的儿童有关 延迟发展,他们可以告知所发现行为变化的神经机制 干预。假设:预计,与等待列表对照组相比,婴儿接受了 贾斯珀干预将证明社交沟通技巧的提高,并捕获了变化 行为和电生理学。方法论:总共有60名TSC年龄12-36个月的婴儿将 可以在TSC Research,UCLA和波士顿儿童的两个网站上招募两个网站 医院,每个婴儿随机进行治疗或等待列表对照组。等待列表控制设计允许 所有婴儿都接受干预措施,同时仍保持非治疗比较组。治疗将 包括12周的每周干预课程。评估(临床,行为和脑电图)将是 在治疗之前,完成后,完成3个月以及完成后12个月进行治疗。 控件将在同一时间点进行评估,然后在第6个月开始干预。 评估将包括社会沟通技巧,认知,语言和语言和 自适应功能以及静息状态大脑活动,视觉和面部处理的脑电图。影响:早期 干预措施改善了ASD的认知和行为结果,但是没有研究研究这些影响 TSC婴儿的靶向早期行为干预。早期干预功效的证据将 证明其对所有TSC婴儿的价值合理,改善了发育效果并减轻症状 导致TSC中神经发育障碍的诊断。而且,这项研究与 通过将脑电图生物标志物的整合与神经发育障碍的干预研究 行为措施,因为这种方法可能会更容易捕获治疗在言语中的影响 并发育延迟的婴儿。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Shafali Spurling Jeste其他文献

Odd Gait, Clumsiness, and Other Abnormal Motor Signs: Clinical Insights From the Australian Autism Spectrum Disorder Motor Research Program
  • DOI:
    10.1016/j.jaac.2016.07.144
  • 发表时间:
    2016-10-01
  • 期刊:
  • 影响因子:
  • 作者:
    Nicole Rinehart;Shafali Spurling Jeste
  • 通讯作者:
    Shafali Spurling Jeste

Shafali Spurling Jeste的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Shafali Spurling Jeste', 18)}}的其他基金

Toward Scalable Biomarker-Based Prediction of ASD in High-Risk Infants
基于生物标志物的高危婴儿自闭症谱系障碍 (ASD) 可扩展预测
  • 批准号:
    10452439
  • 财政年份:
    2021
  • 资助金额:
    $ 51.87万
  • 项目类别:
Toward Scalable Biomarker-Based Prediction of ASD in High-Risk Infants
基于生物标志物的高危婴儿自闭症谱系障碍 (ASD) 可扩展预测
  • 批准号:
    10475316
  • 财政年份:
    2021
  • 资助金额:
    $ 51.87万
  • 项目类别:
Toward scalable biomarker-based prediction of ASD in high-risk infants
基于生物标志物的高危婴儿自闭症谱系障碍 (ASD) 可扩展预测
  • 批准号:
    10023280
  • 财政年份:
    2019
  • 资助金额:
    $ 51.87万
  • 项目类别:
Electrophysiological biomarkers of sleep and cognition in Dup15q syndrome
Dup15q 综合征睡眠和认知的电生理生物标志物
  • 批准号:
    9810069
  • 财政年份:
    2019
  • 资助金额:
    $ 51.87万
  • 项目类别:
Mechanisms of Change with Early Intervention in Tuberous Sclerosis Complex
结节性硬化症早期干预的变化机制
  • 批准号:
    10380038
  • 财政年份:
    2017
  • 资助金额:
    $ 51.87万
  • 项目类别:
Mechanisms of Change with Early Intervention in Tuberous Sclerosis Complex
结节性硬化症早期干预的变化机制
  • 批准号:
    10461690
  • 财政年份:
    2017
  • 资助金额:
    $ 51.87万
  • 项目类别:
3/5-The Autism Biomarkers Consortium for Clinical Trials
3/5-自闭症临床试验生物标志物联盟
  • 批准号:
    10224937
  • 财政年份:
    2015
  • 资助金额:
    $ 51.87万
  • 项目类别:
3/5-The Autism Biomarkers Consortium for Clinical Trials
3/5-自闭症临床试验生物标志物联盟
  • 批准号:
    10439670
  • 财政年份:
    2015
  • 资助金额:
    $ 51.87万
  • 项目类别:
3/5-The Autism Biomarkers Consortium for Clinical Trials
3/5-自闭症临床试验生物标志物联盟
  • 批准号:
    10675097
  • 财政年份:
    2015
  • 资助金额:
    $ 51.87万
  • 项目类别:
3/5-The Autism Biomarkers Consortium for Clinical Trials
3/5-自闭症临床试验生物标志物联盟
  • 批准号:
    10083890
  • 财政年份:
    2015
  • 资助金额:
    $ 51.87万
  • 项目类别:

相似国自然基金

面向康复护理机器人的人机信任度评估方法与任务影响机制研究
  • 批准号:
    62306195
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
长期护理保险制度与老年照护供给效率及公平:影响机制与政策措施
  • 批准号:
    72274117
  • 批准年份:
    2022
  • 资助金额:
    45.00 万元
  • 项目类别:
    面上项目
长期护理保险制度与老年照护供给效率及公平:影响机制与政策措施
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    45 万元
  • 项目类别:
    面上项目
深海土阻力时变特性影响下管线轴向走管的变形机理及防护理论研究
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
深海土阻力时变特性影响下管线轴向走管的变形机理及防护理论研究
  • 批准号:
    52101325
  • 批准年份:
    2021
  • 资助金额:
    24.00 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Targeting Alcohol-Opioid Co-Use Among Young Adults Using a Novel MHealth Intervention
使用新型 MHealth 干预措施针对年轻人中酒精与阿片类药物的同时使用
  • 批准号:
    10456380
  • 财政年份:
    2023
  • 资助金额:
    $ 51.87万
  • 项目类别:
Implementing Evidence-Based Treatment for Common Mental Disorders in HIV Clinics in Ukraine
在乌克兰艾滋病毒诊所对常见精神疾病实施循证治疗
  • 批准号:
    10762576
  • 财政年份:
    2023
  • 资助金额:
    $ 51.87万
  • 项目类别:
Anxiety in Youth with Autism Spectrum Disorder
自闭症谱系障碍青少年的焦虑
  • 批准号:
    10784337
  • 财政年份:
    2023
  • 资助金额:
    $ 51.87万
  • 项目类别:
Accelerated Neuromodulation of Prefrontal Circuitry during Clozapine Treatment
氯氮平治疗期间前额叶回路的加速神经调节
  • 批准号:
    10726660
  • 财政年份:
    2023
  • 资助金额:
    $ 51.87万
  • 项目类别:
Targeting adolescent depression symptoms using network-based real-time fMRI neurofeedback and mindfulness meditation
使用基于网络的实时功能磁共振成像神经反馈和正念冥想针对青少年抑郁症状
  • 批准号:
    10581837
  • 财政年份:
    2023
  • 资助金额:
    $ 51.87万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了